Evandro de Azambuja: Improving ESMO’s membership survey
Evandro de Azambuja, the Director of Membership for the European Society for Medical Oncology, posted on LinkedIn:
“The ESMO Membership Committee would like to gain an understanding about what benefits you value most and how we can continue to improve our membership offer. Deadline to complete this survey: 16 December 2024.”
Giuseppe Curigliano, the Director of the Early Drug Development Division at the European Institute of Oncology, shared this post on LinkedIn adding:
“We need your active engagement on this survey ESMO.”
Evandro de Azambuja is the Director of Membership for the European Society for Medical Oncology (ESMO) for the 2023-2024 term and the President of the Belgian Society of Medical Oncology (BSMO) from 2023 to 2026. He leads the Medical Support Team at the Jules Bordet Institute, previously known as the BREAST Data Centre. He has an extensive background in clinical research, particularly in breast cancer and clinical trials.
Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues. He is the Editor-in-Chief of ESMO Open, the European Society for Medical Oncology’s open-access journal.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023